BASIS~ (603) 893-3758

NEWS

NEWS

News

See you are these fall conferences!

NEWS     ISPE Boston Area Chapter Product Show September 20 | Foxboro, MA Booth #W62   22nd Annual Contract Pharma September 21-22 | New Brunswick, NJ   Technology Symposium October 2-3 | Holmdel, NJ Booth #609   2023 PDA Pharmaceutical Microbiology Conference October...

read more

Director’s Corner: Jeff Heiser

Jeff Heiser is the Chief Scientific Officer (CSO) of Microbial and Advanced Therapeutic Platforms at Boston Analytical. After graduating from the University of New Hampshire with a degree in Microbiology Research in 2007, he entered the industry working for Pfizer...

read more

Essential Experts: Chathurika Rathnayake, Ph. D.

Chathurika Rathnayake, Ph. D., is the Manager of Analytical Development at Boston Analytical, Inc. in Salem, NH. She has been with Boston Analytical since 2019, serving first as a Senior Scientist, then as Group Leader, and now in her current role. She oversees a...

read more

Nitrosamine Drug Substance-Related Impurity Testing

Nitrosamine Drug Substance-Related Impurity Testing Ensuring that drug products do not contain nitrosamine compounds is vitally important given their toxicity. Nitrosamines can only form under certain conditions (luckily), however their high toxicity predicates the...

read more

Director’s Corner: Mark Guevarra

Mark comes to Boston Analytical with 16+ years of experience working in the pharmaceutical industry. He currently is the Director of Analytical Development at Boston Analytical. Previously Mark was a Senior Group Leader managing all analytical method...

read more